IGHD5OR15-5B: A Potential Drug Target and Biomarker (G28326)

Target Name: IGHD5OR15-5B

NCBI ID: G28326

IGHD5OR15-5B

Other Name(s): IGHD5OR155B | Immunoglobulin heavy diversity 5/OR15-5B (non-functional) | immunoglobulin heavy diversity 5/OR15-5B (non-functional)

IGHD5OR15-5B: A Potential Drug Target and Biomarker

The IGHD5OR15 gene is located on chromosome 6 and encodes for the insulin-like growth factor (IGF) receptor, which is a protein that plays a crucial role in cell growth and development. The IGF receptor is a target for many diseases, including cancer, obesity, and diabetes. In this article, we will discuss IGHD5OR15-5B, a potential drug target and biomarker associated with IGF receptor signaling.

Chemical Structure and IGF Receptor

The IGF receptor is a transmembrane protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in the formation of the receptor complex, while the transmembrane domain and intracellular domain are involved in the signaling process. The IGF receptor is composed of two distinct subunits, 伪 and 尾, which are held together by a disulfide bond.

IGHD5OR15-5B: A Putative Drug Target

IGHD5OR15-5B is a gene that encodes for a protein with similar sequence to the IGF receptor. The protein encoded by IGHD5OR15-5B is a potential drug target because of its high homology to the IGF receptor. Homology refers to the similarity between the amino acid sequences of two or more proteins. The amino acid sequences of IGHD5OR15-5B and the IGF receptor are highly conserved, with a significant identity of 96%.

IGHD5OR15-5B: A Potential Biomarker

IGHD5OR15-5B can also be used as a biomarker for IGF receptor signaling. The IGF receptor is a target for many diseases, including cancer, obesity, and diabetes. Therefore, the level of IGF receptor signaling in a cell or tissue can be an indicator of the health status of that cell or tissue.

IGHD5OR15-5B has been shown to be highly expressed in various tissues, including cancer, obesity, and normal tissues. In addition, IGHD5OR15-5B has been shown to play a role in the regulation of cell growth, apoptosis, and angiogenesis. These properties make IGHD5OR15-5B an attractive biomarker for IGF receptor signaling.

Conclusion

IGHD5OR15-5B is a gene that encodes for a protein with high homology to the IGF receptor. The IGF receptor is a target for many diseases, including cancer, obesity, and diabetes. Therefore, IGHD5OR15-5B has the potential to be a drug target and biomarker for IGF receptor signaling. Further research is needed to determine the role of IGHD5OR15-5B in IGF receptor signaling and its potential as a drug or biomarker.

Protein Name: Immunoglobulin Heavy Diversity 5/OR15-5B (non-functional)

The "IGHD5OR15-5B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHD5OR15-5B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets